Escherichia coli can respire anaerobically by reducing nitrate, trimethylamine-N-oxide, dimethyl sulfoxide, or fumarate. When nitrate is present, expression of the genes for fumarate (frdABCD), trimethylamine-Noxide, and dimethyl sulfoxide (dmsABC) is repressed while expression of the nitrate reductase (narGHJI) gene is induced. This regulation requires molybdate and is mediated by the narX and narL gene products, which together form a two-component regulatory system. We provide evidence that NarX is a nitrate and molybdenum sensor which activates NarL when nitrate is available to cells. Mutants generated by hydroxylamine mutagenesis were repressed for frdA.lacZ expression even when cells were grown in the absence of nitrate. The mutatpins responsible for three of these nitrate independence (NarX*) phenotypes were localized to narX and further characterized in vivo for their ability to repress frdA-lacZ expression. Two of the mutants (the narX64 and narX71 mutants) had a greatly reduced requirement for molybdenum to function but still responded to nitrate. In contrast, a third mutant (the narX32 mutant) required molybdenum but did not exhibit full repression of frdA-lacZ expression even when nitrate was present. These narX* alleles also caused the induction of nitrate reductase gene expression and the repression of a dmsA-lacZ fusion in the absence of nitrate. Each narX* mutation was determined to lie in an 11-amino-acid region of the NarX polypeptide that follows a proposed transmembrane domain. We suggest that the conformation of the narX* gene products is altered such that even in the absence of nitrate each of these gene products more closely resembles the wild-type NarX protein when nitrate is present. These data establish a clear role for the narX gene product in gene regulation and strongly suggest its role in sensing nitrate and molybdenum.
Escherichia coli can obtain energy via oxidative phosphorylation by reducing a variety of terminal electron acceptors. These include, in order of decreasing potential energy, oxygen, nitrate, trimethylamine-N-oxide (TMAO), dimethyl sulfoxide (DMSO), and fumarate (13, 34) . Production of the enzymes (cytochrome o and d oxidase, nitrate reductase, DMSO and TMAO reductase, and fumarate reductase) for the reduction of each of these respiratory substrates is regulated by anaerobiosis and/or nitrate (2, 3, 17, 26, 29) . During aerobic growth, the nitrate reductase (narGHJI), DMSO and TMAO reductase (dmsABC), and fumarate reductase (frdABCD) genes are expressed at low levels while cytochrome o (cyoABCDE) and d (cydAB) oxidase gene expression is high. Upon oxygen depletion and when nitrate is present, narGHJI gene expression is elevated while the synthesis of the enzymes for the utilization of the other alternative anaerobic electron acceptors is repressed (2, 3, 17-19, 26, 29) . The fumarate reductase and DMSO and TMAO reductase genes are expressed at high levels only when nitrate is either depleted or absent from the anaerobic culture medium.
The mechanism for oxygen regulation of the respiratory pathway genes appears to function independently of nitrate regulation. The aerobic or anaerobic response is mediated in part by the FNR protein (2, 3, 17, 21, 29) , whereas the nitrate response is mediated by at least two other regulatory proteins encoded by the narX (narR) and narL (frdR) genes (3, 14, 18, 19, 30, 31) . Nitrate regulation also appears to require * Corresponding author. the presence of molybdate ions, as chlD strains, which are unable to transport molybdate, are abnormal for nitrate control of narGHJI, dmsABC, and frdABCD gene regulation (3, 15, 23, 30 ; L. V. Kalman, Ph.D. thesis, University of California, Los Angeles, 1990 ). The narX and narL genes are adjacent to each other and map at 27 min on the E. coli chromosome (18, 19, 29, 31) . They have been cloned, and their DNA sequences have been determined (9, 24, 32) . The genes encode proteins of 66 and 23 kDa, respectively (9, 24, 32) . Comparison of the predicted amino acid sequences of NarL and NarX with those of other bacterial proteins reveals similarities to the two-component family of regulatory proteins (e.g., the ompR-envZ, virA-virG, and phoRphoB gene products; 9, 24, 32) . In such systems, one protein component functions as an environmental sensor to detect availability or change in an environmental signal. It then relates this information to a second protein, known as the receiver protein, which responds to either activate or repress gene expression upon binding at a DNA regulatory site (25, 33) . NarX is homologous in its N-terminal domain to the sensor proteins, and NarL is homologous at its C-terminal domain to the receiver proteins (9, 24, 32) . The NarX protein may thus be involved in sensing the availability of nitrate and, possibly, molybdate. We propose that, in the presence of these two anions, NarX modifies NarL, which is then able to activate nitrate reductase (narGHJI) gene expression and repress DMSO and TMAO reductase (dmsABC) and fumarate reductase (frdABCD) gene expression.
In this study, we present further evidence for a model of NarX and NarL interaction. We isolated mutations of narX 
MATERIALS AND METHODS
Bacterial strains, bacteriophages, and plasmids. The E. coli K-12 strains, phages, and plasmids used in this study are listed in Table 1 . The lysogenized AJ100 in strain LK1351 was removed by coinfection as previously described (19) , and XLK1 was introduced into the chromosome. This strain was subsequently transduced to recA srl::TnJO with a P1 lysate prepared on strain DW4 to yield strain LK3012 (narX recA). By a similar method, XLK1 was removed from LK3012(XLK1) (narX), and XPC25 (dmsA'-'lacZ) was introduced to yield LK3012(XPC25) (narX). Transductions and lysogenies were performed as previously described (27) .
Media. For strain and plasmid constructions, cells were grown in Luria broth or on solid medium with chloramphenicol, tetracycline, or ampicillin present at a concentration of 30, 20, or 100 ,ug/ml, respectively, as needed. MacConkey agar (Difco)-lactose (1%)-fumarate (40 mM) (MLF) plates containing the appropriate antibiotics were used for mutant isolation and screening. Sodium nitrate (40 mM) and sodium molybdate (100 ,uM) were added as needed. Cells were grown for enzyme assays in minimal medium supplemented with 40 mM glucose and 40 mM fumarate as previously described (18, 28) . Nitrate, ampicillin, or molybdate was present as needed. The medium was made anaerobic by boiling and by cooling under a stream of oxygen-free nitrogen gas (19) . The procedure into 10-ml anaerobic culture tubes and sealed with butyl rubber stoppers and aluminum crimps. Tubes of medium were inoculated from overnight cultures grown under identical conditions, and the cells were allowed to double four or five times in the mid-exponential phase prior to being harvested (optical density at 600 nm, 0.40 to 0.45; Kontron Uvikon 810 spectrophotometer).
Hydroxylamine mutagenesis. Approximately 5 jig of plasmid pLK63 (narX+L+) was treated with the chemical mutagen hydroxylamine for 3.5 h at 550C as previously described (4). The DNA was diluted to 5 ml in 10 mM Tris-1 mM EDTA buffer (pH 7.5) and ethanol precipitated (22) .
Enzyme assays. 3-Galactosidase and nitrate reductase were assayed as previously described (18) .
Plasmid construction. All transformation, plasmid isolation, and cloning procedures were performed as described previously (22) . DNA fragments used for cloning experiments were isolated from 0.8% agarose gels and purified with Geneclean (Bio 101, La Jolla, Calif.). The 4.9-kb narXLcontaining fragment from plasmid pLK63 or the corresponding hydroxylamine-treated regions from plasmids pLK63X4, pLK63X5, pLK63X6, pLK63X7, pLK63X8, and pLK63L3 were cloned into plasmid vector pZ152 to yield plasmids pLK5000, pLK5400, pLK5500, pLK5640, pLK5710, pLK 5810, and pLK5320, respectively. The orientation of the inserted fragment in these plasmids was the same as that in pLK9 (18) .
Derivatives of plasmids pLK5640, pLK5710, and pLK5320 were constructed to determine the locations of the mutations responsible for the nitrate independence phenotype (Fig. 1 ). For example, the PstI fragment or the BglII-BamHI fragment was deleted to yield plasmids lacking either the intact narX gene or the intact narL gene, respectively. The -3.5-kb BamHI-XhoI fragment, the -2-kb PstI fragment, or the 0.4-kb XhoI-PstI fragment was exchanged with the corresponding wild-type sequence in plasmid pLK5000 to further localize the region responsible for the mutant phenotype ( Fig. 1 ). Plasmids pLK5644, pLK5714, and pLK5324 contain the 400-bp mutagenized region between the XhoI and PstI sites ( Fig. 1 ) cloned into pLK5000 in place of the corresponding wild-type fragment. For DNA sequence analysis, the 400-bp XhoI-PstI fragment from plasmids pLK5644, pLK5714, pLK5324, and pLK5000 was isolated and cloned into the large SalI-PstI fragment of plasmid vector pUC18 or pUC19.
DNA sequence analysis. A double-stranded DNA template from plasmids pUC18 and pUC19 and containing the XhoIPstl fragment derived from pLK5324, pLK5644, or pLK5714 was prepared by alkaline lysis. The DNA template was primed and sequenced by the dideoxy chain termination method.
RESULTS
Isolation of narX* mutants. To obtain mutations in the narX and/or narL genes that caused repression of a frdA'-'lacZ protein fusion even when cells were grown in the absence of nitrate, we mutagenized plasmid pLK63 (narX+ narL+) with the chemical mutagen hydroxylamine. Treated DNA was transformed into strains LK3015 (narX narL+) and LK3018 (narX+ narL), and the resulting transformants were plated onto MLF medium containing chloramphenicol. Either strain containing plasmid pLK63 (narX+ narL+) formed red colonies on this medium, because expression of the frdA'-'lacZ fusion located on the lysogenic XLK1 phage is derepressed in the absence of nitrate (18) . Mutants that contained either a narX* or a narL* allele, which would cause repression offrdA'-'lacZ expression in the absence of nitrate, were expected to form white colonies on this medium. Of 405 transformants examined, 6 had a white colony phenotype after 24 h of aerobic incubation. These were restreaked for purity, and plasmid DNA was isolated and stocked for further study. The plasmids were designated pLK63X4 to pLK63X8 and pLK63L3 ( Table 1) .
Localization of the mutations to narX. To determine whether the mutation contained on each mutant plasmid was located in narX, narL, or the plasmid vector, we isolated the 4.9-kb HindIII fragment from each plasmid (pLK63X4, pLK63X5, pLK63X6, pLK63X7, pLK63X8, and pLK63L3) and recloned it into a nonmutagenized plasmid vector (pZ152) to create plasmids pLK5400, pLK5500, pLK5640, pLK5710, pLK5810, and pLK5320, respectively. When plated on MLF-ampicillin plates, strain LK3015 containing plasmid pLK5640, pLK5710, or pLK5320 formed white colonies, indicating that the mutation(s) resided in the 4.9-kb HindIII insert and not in the vector. Strain LK3015 containing plasmid pLK5400, pLK5500, or pLK5810 formed red colonies, indicating that the parent plasmid (pLK63X4, pLK63X5, or pLK63X8, respectively) contained a mutation in the vector. Further examination of these plasmids revealed that they were present in high copy numbers that apparently resulted in the mutant phenotype by overproduction of the NarL protein (data not shown). These three mutants were not examined further.
To determine whether the mutation(s) responsible for the mutant phenotype was in the narX gene or the narL gene, we either deleted or replaced regions of the 4.9-kb HindIII fragment in plasmids pLK5320, pLK5640, and pLK5710 (Fig. 1) . The resulting plasmids were transformed into LK3015 (narXL+) and plated on MLF-ampicillin indicator medium to test for the mutant phenotype. Formation of white colonies indicated that the subcloned DNA fragment contained the mutation(s) responsible for the nitrate independence (mutant) phenotype. The lesions were found to be located within a 400-bp region of the narX gene between the XhoI and PstI sites. One of the narX* plasmids that contained a BgIII BamHI deletion (represented in Fig. 1, line 3) failed to exhibit the mutant phenotype unless a wild-type narL+ gene was provided in trans. This result was also seen previously and indicates that the narX gene copy number must be similar to that of narL (see Table 3 in reference 19) .
DNA sequence analysis of narX* mutants. To identify the location of each mutation, we cloned the 400-bp XhoI-PstI fragment from plasmids pLK5644, pLK5714, and pLK5324 into plasmids pUC18 and pUC19 and sequenced it. A single C-to-T transition was identified in each mutant plasmid (Fig.  2) . The mutations in clones pLK5714, pLK5324, and pLK5644 resulted in an amino acid replacement of a glycine residue at amino acid position 205 with arginine, a glutamate at position 208 with lysine, and an alanine at position 215 with threonine, respectively. These alleles were called narX32, narX64, and narX71, respectively.
Phenotype of mutant narX* clones in narL, narX, chiD, and wild-type strains. To determine the phenotype caused by the narX* alleles in various chromosomal backgrounds, we transformed plasmids pZ152, pLK5000, pLK5320, pLK5640, and pLK5710 into the following strains: LK3018 (narL recA), LK3015 (narX recA), LK3014 (chlD recA), and LK3017 (recA). Transformants were plated on MLF-ampicillin indicator medium with or without 100 ,uM molybdate (Table 2) . Strains containing plasmid pZ152 or pLK5000 formed red colonies on the indicator medium because of their inability to repress expression of the frdA'-'lacZ fusion. In contrast, the narX, narL, or wild-type strain containing a narX* plasmid formed white colonies on this indicator medium (Table 2) . These results indicate that the mutant narX* alleles contained on each plasmid were dominant (in multicopy) over the wild-type copy of narX on the chromosome.
Molybdenum ions are required in addition to nitrate for normal repression of fumarate reductase and TMAO and To determine whether multiple copies of the narL+ gene or the narX+ gene alone could account for the abovedescribed findings, we transformed a narX strain and a wild-type strain with plasmid pLK634 (narL+) or plasmid pLK633 (narX+) and assayed for frdA'-'lacZ expression (Table 3) . When grown in the absence of nitrate, all strains exhibited similar levels of P-galactosidase activity relative to either strain with plasmid pZ152. These results indicated that the presence of a multicopy narL+ or narX+ plasmid did not account for the narX* effect onfrdA'-'lacZ expression when cells were grown without nitrate. These findings were reported previously (19) .
Effect of the chMD allele and molybdenum on nitrate regulation of frdA'-'lacZ expression. The effect of molybdenum availability on the function of the narX* alleles was determined by assaying a chlD strain, LK3014, containing the mutant narX* plasmids (Table 4) . Plasmid pLK5324 containing the narX32 allele encoded a molybdate-sensitive NarX protein, as evidenced by the two-to threefold repression of frdA'-'lacZ expression when this ion was present in the culture medium, which lacked nitrate. However, the narX32 allele was also relatively insensitive to nitrate, as the addition of this compound caused only a further threefold repression of frdA'-'lacZ expression. In contrast, the other two narX* mutants (the narX64 and narX71 mutants) were less sensitive to molybdenum, as shown by a relatively small increase in frdA'-'lacZ repression when it was added to the medium. However, the chiD strain containing either of these VOL. 172, 1990 on August 27, 2017 by guest http://jb.asm.org/ Downloaded from (19) .
two narX* mutant alleles exhibited a marked repression of frdA'-'lacZ expression in response to nitrate. It is interesting to note that the presence of a multicopy narX+L' plasmid, pLK5000, in the chlD strain allowed nitrate-dependent repression of frdA'-'lacZ expression even when molybdate was not added to the medium. The addition of molybdate, however, caused an additional 10-fold repression of frdA'-'lacZ expression. This result may indicate that the molybdate requirement was partially overcome when wild-type NarX and NarL were present in multiple copies or that molybdate was not effectively limited by the chlD allele. Effect of narX* mutations on expression of a dmsA'-'lacZ fusion. A 12-fold nitrate repression of dmsABC gene expression was previously shown to be mediated by narL and narX (3) . To determine the effect of the various narX* alleles on this process, we monitored the expression of a dmsA'-'IacZ fusion in strain LK3012(XPC25) bearing each of the narX* plasmid derivatives. Cells were grown as described for the frdA'-'lacZ expression studies reported in Table 3 . The results of these studies indicate that the mutant narX* alleles had a similar but less dramatic effect on dmsA'-'lacZ expression than seen on frdA'-'lacZ expression (data not shown).
Effect of narX* mutations on nitrate reductase activity. The induction of nitrate reductase gene expression in cells grown in the presence of nitrate has been shown to be mediated by narL (14, 18, 19, (29) (30) (31) and narX (19) . To establish the effect of the various narX* alleles on nitrate reductase synthesis, we measured the levels of this enzyme in a narX strain (LK3012) containing each narX* plasmid (Table 5) . When strains containing the narX32, narX64, and narX71 alleles were grown in the absence of nitrate, each contained elevated levels of nitrate reductase (e.g., 71-, 29-, and 31-fold, respectively); there was a 2-fold increase in strain LK3012 containing plasmid pLK5000 (narX+L+) relative to that in a strain containing plasmid pZ152. When nitrate was added to the culture medium, levels of the enzyme were further elevated in the narX64 and narX71 plasmid-bearing strains ( Table 5) . As shown previously for the regulation of frdA'-'IacZ and dmsA'-'lacZ expression, these two NarX* proteins still exhibited partial nitrate-sensing ability, whereas the narX32 gene product did not. As an additional control, a narL+ plasmid that lacked narX+ (pLK634) was introduced into a narX+ strain to test whether excess NarL produced in trans over NarX could activate nitrate reductase production in a similar fashion. It could not. The addition of narL+ in cis to narX+ (e.g., pLK5000) also did not cause a significant activation of nitrate reductase activity when cells were grown in the absence of nitrate. The NarX* phenotype is apparently not due to the overproduction of NarL or NarX.
DISCUSSION
In previous studies, we demonstrated that the repression of fumarate reductase and DMSO and TMAO reductase gene expression as well as the induction of nitrate reductase synthesis in response to nitrate is controlled by the narX (frdRl, narR) and narL (frdR2) gene products (3, 18, 19 (Fig. 2) . This region immediately follows the second proposed transmembrane domain and is predicted to be at or near the inner surface of the cytoplasmic membrane. When cells were grown in the absence of nitrate, each narX* mutation resulted in the repression of frdA'-'lacZ and dmsA'-'lacZ expression and in the induction of nitrate reductase synthesis, compared with a wild-type strain (Tables 3 and 5) . Upon the addition of nitrate, two of the narX* alleles, narX64 and narX71, caused complete repression and induction of the respiratory enzymes while the remaining allele (narX32) did not. Strains bearing plasmids with the narX64 and narX71 alleles were also relatively independent of molybdenum for activity, unlike strains with the narX32 allele.
The above-described findings support a working model for the action of the narX* mutants (Fig. 3) 3 . Proposed model for the interaction of the narX, narX*, and narL gene products in the repression or activation of the anaerobic respiration-associated genes in E. coli. In the absence of nitrate (NO3-), the wild-type NarX protein is unable to convert the inactive form of NarL (NarLj) to the active form (NarLA). In the presence of nitrate (and molybdenum), the wild-type NarX protein changes conformation and is able to convert NarL, to NarLA, which is then able to bind DNA and effect the expression of nitrate-controlled genes. In both the presence and the absence of nitrate, the mutant NarX protein (NarX*) is in a conformation more like that of the wild-type NarX protein in the presence of nitrate. Thus, NarX* is able to convert NarL, to NarLA even in the absence of nitrate. The locations of the narX* mutations are indicated by the asterisk. P, Periplasmic space; CM, cytoplasmic membrane; C, cytoplasm. The N and C termini of the NarX protein are indicated by N and C, respectively. narX64 and narX71 gene products are still able to interact with nitrate and cause the further activation of NarL. In contrast, the narX32 gene product does not respond in the same way to the presence of nitrate, suggesting either that it is somehow impaired in its ability to detect nitrate or that it is impaired in its ability to further activate NarL.
Since molybdenum must be transported into the cell for the proper function of NarX and NarL (as shown by the inability of a chID molybdate transport mutant to cause the repression of fumarate reductase expression in the presence of nitrate; 15, 19; Kalman, Ph.D. thesis), this ion must somehow interact with the cytoplasmic region of one of these two regulatory proteins. Nitrate conceivably interacts with the NarX protein region exposed to the periplasm, whereas the site(s) for molybdenum interaction may lie elsewhere in NarX, although this idea has yet to be tested. It is also by no means clear whether the locations for molybdenum and/or nitrate interaction are limited to the NarX protein. Additional proteins could conceivably aid in this process. However, it is probable that the conformation of each mutant NarX* protein is more like that of the wild-type NarX protein when nitrate is present, so as to preempt the effect of molybdenum and/or nitrate binding.
The NarX and NarL regulatory proteins clearly participate in detecting molybdate availability in the cell environment as well as nitrate availability. This type of regulation allows the activation of nitrate reductase gene expression only under conditions in which a functional molybdoenzyme can be formed. It prevents the unnecessary synthesis of the nitrate reductase holoenzyme when molybdenum is unavailable to the cell in sufficient amounts even when nitrate is present. Fumarate reductase, which does not require molybdenum as an essential cofactor for catalytic activity, may then be synthesized to enable the cell to respire with fumarate.
The NarX* mutants isolated in this study clearly implicate NarX in nitrate and molybdenum signaling and show it to be required for the repression and activation of genes regulated in response to nitrate. These data also establish that NarL can act both as an activator and as a repressor under the same cell growth conditions. Previous reports indicated that narX strains could still induce the expression of nitrate reductase (30, 31) and repress frdA'-'lacZ expression and thus concluded that NarX may not be essential for nitrate regulation. The NarX* mutants isolated in this work, however, indicate that NarX is clearly involved in the regulation of nitrate-controlled respiratory genes.
It has been previously suggested that there may be an internal promoter for the expression of narL that is located within the narX gene (5, 24) . Thus, it may be argued that the properties of the NarX* mutants may simply be the result of a mutation in this promoter that results in the overexpression of NarL (5). We ruled out this possibility by measuring frdA'-'lacZ activity in narX strains containing a plasmid encoding narX32L, narX64L, or narX71L as well as a plasmid (pLK634) encoding narL+ alone (e.g., to determine the effect of having narX* on one plasmid and narL+ on another). In this combination, readthrough from narX* into narL is not possible, since the genes are contained on separate plasmids. We found that the repression of frdA'-'lacZ expression occurred in the absence of nitrate in strains containing plasmids bearing narX32, narX64, or narX71 but not in strains containing narX+ (data not shown). These results indicate that the ability to regulate frd gene expression in the absence of nitrate is not simply due to the overproduction of NarL by readthrough of narL transcription from the narX gene but rather is due to an altered activity of the NarX protein.
As with other two-component systems, such as NtrBNtrC, OmpR-EnvZ, VirA-VirG, and CheA-CheY (6, 10, 12, 16, 20, 35) , it is possible that the interaction of NarX and NarL involves phosphorylation. If this is true, the NarX* mutants may be altered in the rate of autophosphorylation and/or in the rate of phosphorylation and dephosphorylation of the NarL protein. NarX* mutants presumably activate NarL even when cells are grown in the absence of nitrate.
By this scheme, NarL would be phosphorylated and active even in the absence of nitrate. Analysis of narL mutants that relieve the NarX* phenotype will be interesting in this regard.
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